+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Synthesis & Manufacturing Market - Global Forecast 2026-2032- Product Image
mRNA Synthesis & Manufacturing Market - Global Forecast 2026-2032- Product Image
Sale

mRNA Synthesis & Manufacturing Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6021445
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The mRNA Synthesis & Manufacturing Market is projected to reach USD 3.64 Billion in 2026. It is expected to continue growing at a CAGR of 9.50%, reaching USD 6.29 Billion by 2032.

mRNA Synthesis and Manufacturing: Executive Overview

mRNA synthesis and manufacturing encompasses template design, enzymatic or chemical production, purification, analytical characterization, formulation, and quality-controlled drug-substance production. The field supports vaccines, protein-replacement therapies, cancer immunotherapies, and emerging gene-editing applications. Its strategic importance is shaped by the need to preserve RNA integrity, control impurities, maintain reproducibility, and move efficiently from development into regulated manufacturing.

Platform Industrialization Is Reshaping mRNA Production

The landscape is shifting from small-batch experimentation toward standardized, modular, and digitally controlled processes. Important priorities include reliable plasmid and DNA-template supply, improved transcription performance, robust purification, lipid-nanoparticle formulation, closed processing, and scalable fill-finish operations. Manufacturers are also placing greater emphasis on comparability, process validation, analytical release testing, cold-chain resilience, and regional supply security.

Artificial Intelligence Improves Design, Control, and Quality Workflows

Artificial intelligence can support mRNA sequence optimization, codon selection, structure analysis, impurity prediction, formulation screening, process monitoring, and deviation investigation. Machine-learning systems are particularly useful when integrated with laboratory automation and high-throughput experimentation, enabling faster comparison of process conditions. Adoption remains dependent on representative datasets, explainable outputs, cybersecurity, data integrity, and validation aligned with good manufacturing practice; AI should augment qualified scientific and regulatory judgment rather than replace it.

Regional Insights: Capabilities Are Expanding Across Six Production Hubs

North America combines advanced biotechnology infrastructure, strong translational research, and mature regulatory capabilities, while Latin America is focused on strengthening local vaccine and biologics manufacturing and reducing external dependence. Europe benefits from established pharmaceutical quality systems and cross-border research networks. The Middle East is investing in life-science capacity and technology transfer, and Africa is prioritizing public-health resilience, workforce development, and manufacturing partnerships. Asia-Pacific spans highly developed biomanufacturing ecosystems in economies such as Japan, South Korea, Australia, and China alongside rapidly expanding capabilities in India and Southeast Asia; supply-chain localization and regulatory harmonization remain central themes.

Group Insights: Alliances and Trade Blocs Shape Resilience

ASEAN economies are developing complementary research, manufacturing, and distribution capabilities, with regulatory alignment remaining important for regional scale-up. BRICS members reflect diverse strengths in research, raw materials, manufacturing, and public-health procurement, while the European Union benefits from coordinated regulatory structures and integrated industrial networks. G7 economies generally emphasize advanced innovation, quality systems, and supply-chain resilience. GCC states are building biotechnology capacity through investment and partnerships, and NATO members are increasingly attentive to biosecurity, continuity of essential supplies, and dual-use governance.

Country Insights: National Strengths Reflect Different Strategic Priorities

Australia emphasizes translational research, biomanufacturing capability, and preparedness; Brazil and Mexico are focused on strengthening domestic production and public-health resilience. Canada combines academic innovation with regulated bioprocessing, while the United States has broad capabilities spanning discovery, clinical development, and commercial manufacturing. China and India are expanding research and production capacity, and Japan and South Korea bring strong pharmaceutical engineering and quality expertise. France, Germany, Italy, Spain, and the United Kingdom benefit from sophisticated life-science ecosystems and regulatory experience. Russia retains scientific and manufacturing assets but faces constraints related to international access, technology, and supply chains.

Priorities for Leaders: Build Flexible, Qualified, and Data-Ready Operations

Industry leaders should qualify multiple sources for critical inputs, design processes for scale from the outset, and invest in analytical methods that can detect sequence, purity, potency, and formulation risks early. Modular facilities, standardized technology platforms, and strong technology-transfer packages can improve responsiveness across products and sites. Organizations should establish AI governance with validated datasets, human review, audit trails, and cybersecurity controls. Partnerships with regulators, academic centers, contract manufacturers, and regional health authorities can strengthen workforce capabilities, accelerate comparability work, and improve continuity during demand or supply disruptions.

Research Methodology: Evidence-Based Assessment of the Manufacturing Value Chain

This executive summary uses a structured assessment of the mRNA synthesis and manufacturing value chain, covering upstream template preparation, transcription, purification, formulation, analytical control, fill-finish, logistics, and regulatory readiness. Insights are organized across required regions, economic and security groupings, and countries, with emphasis on publicly documented scientific, industrial, policy, and infrastructure developments. The assessment intentionally excludes market estimates, market shares, forecasts, and company-specific claims, and distinguishes established capabilities from emerging priorities.

Conclusion: Reliability, Localization, and Quality Will Define Progress

mRNA synthesis and manufacturing is moving toward more integrated, automated, and resilient production systems. Success will depend on consistent product quality, scalable processes, dependable inputs, regulatory confidence, and skilled multidisciplinary teams. Regional capacity building and cross-border collaboration can broaden access, while responsible AI adoption can improve development and operational control. Leaders that combine platform standardization with flexible manufacturing and rigorous data governance will be best positioned to support the next generation of mRNA applications.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. mRNA Synthesis & Manufacturing Market, by Service Type
7.1. Introduction
7.2. Custom mRNA Synthesis
7.2.1. Client-Specific mRNA Orders
7.2.2. Tailored Research Specifications
7.3. Standard mRNA Production
7.3.1. Cataloged mRNA Variants
7.3.2. Off-the-Shelf mRNA Selections
8. mRNA Synthesis & Manufacturing Market, by mRNA Modality
8.1. Introduction
8.2. Non-Replicating Linear mRNA
8.2.1. Nucleoside-Modified Constructs
8.2.2. Unmodified Nucleoside Constructs
8.3. Self-Amplifying mRNA
8.3.1. Alphavirus-Derived Replicons
8.3.2. Flavivirus-Derived Replicons
8.4. Circular RNA
8.4.1. Enzymatic Ligation Circularization
8.4.2. Chemical Ligation Circularization
9. mRNA Synthesis & Manufacturing Market, by Offering
9.1. Introduction
9.2. Materials & Reagents
9.2.1. RNA Polymerases
9.2.2. Capping Enzymes & Cap Analogs
9.2.3. Nucleotides & Modified Nucleosides
9.2.4. DNA Templates & Plasmids
9.3. Instruments & Equipment
9.3.1. IVT Reaction Systems & Mixers
9.3.2. Chromatography Skids & Columns
9.3.3. Tangential Flow Filtration Systems
9.3.4. Microfluidic Formulation Platforms
9.3.5. Fill-Finish & Aseptic Equipment
9.4. Software & Digital Solutions
9.4.1. Electronic Batch Records
9.4.2. Process Modeling & Digital Twins
9.4.3. Data Integrity & Quality Management Systems
9.4.4. LIMS & Laboratory Informatics
9.5. Manufacturing Services
9.5.1. Sequence Design & Construct Engineering
9.5.2. Process Development & Optimization
9.5.3. GMP Drug Product Manufacturing
9.5.4. Technology Transfer & Scale-Up
9.6. Testing & Release Services
9.6.1. Method Development & Validation
9.6.2. In-Process Testing
9.6.3. Release Testing
9.6.4. Stability Studies
9.6.5. Comparability & Characterization
10. mRNA Synthesis & Manufacturing Market, by Manufacturing Process
10.1. Introduction
10.2. Advanced LNP Formulation Technology
10.3. Enzymatic Capping & Cap Analogues
10.4. Genetic Engineering & Codon Optimization
10.5. In Vitro Transcription
10.6. Plasmid DNA Template
10.7. Polyadenylation
10.8. RNA Purification Techniques
11. mRNA Synthesis & Manufacturing Market, by Manufacturing Scale
11.1. Introduction
11.2. Commercial Scale
11.3. Lab Scale
11.4. Pilot Scale
12. mRNA Synthesis & Manufacturing Market, by Technology
12.1. Introduction
12.2. In Vitro Synthesis
12.3. In Vivo Synthesis
13. mRNA Synthesis & Manufacturing Market, by Application
13.1. Introduction
13.2. Therapeutics
13.2.1. Cancer immunotherapy
13.2.2. Rare Genetic Disease Treatments
13.2.3. Gene Editing Applications
13.3. Vaccines
13.3.1. Infectious Disease Vaccines
13.3.2. Veterinary Vaccines
13.3.3. Pandemic Preparedness Vaccines
13.4. Research & Discovery
13.4.1. Preclinical Research
13.4.2. Drug Discovery Studies
14. mRNA Synthesis & Manufacturing Market, by Usage
14.1. Introduction
14.2. Human Use
14.3. Veterinary Use
15. mRNA Synthesis & Manufacturing Market, by End-User
15.1. Introduction
15.2. Academic & Research Institutes
15.2.1. Government Research Bodies
15.2.2. University Laboratories
15.3. Contract Manufacturing Organizations
15.4. Pharmaceutical & Biotechnology Companies
16. mRNA Synthesis & Manufacturing Market, by Region
16.1. Introduction
16.2. Europe
16.3. Asia-Pacific
16.4. North America
16.5. Latin America
16.6. Africa
16.7. Middle East
17. mRNA Synthesis & Manufacturing Market, by Group
17.1. Introduction
17.2. NATO
17.3. G7
17.4. European Union
17.5. BRICS
17.6. ASEAN
17.7. GCC
18. mRNA Synthesis & Manufacturing Market, by Country
18.1. Introduction
18.2. United States
18.3. China
18.4. Germany
18.5. United Kingdom
18.6. Japan
18.7. Canada
18.8. India
18.9. France
18.10. Brazil
18.11. Mexico
18.12. Italy
18.13. Australia
18.14. Russia
18.15. Spain
18.16. South Korea
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. Market Concentration Analysis, 2025
19.2.1. Concentration Ratio (CR)
19.2.2. Herfindahl Hirschman Index (HHI)
19.3. Recent Developments & Impact Analysis, 2025
19.4. Product Portfolio Analysis, 2025
19.5. Benchmarking Analysis, 2025
20. Company Profiles
20.1. Thermo Fisher Scientific Inc.
20.2. Danaher Corporation
20.3. Merck KGaA
20.4. Lonza Group Ltd.
20.5. Samsung Biologics Co., Ltd.
20.6. Sartorius AG
20.7. WuXi Biologics (Cayman) Inc.
20.8. Catalent, Inc.
20.9. ST Pharm Co., Ltd.
20.10. GenScript Biotech Corporation
20.11. Promega Corporation
20.12. New England Biolabs, Inc.
20.13. Takara Bio Inc.
20.14. TriLink BioTechnologies LLC by Maravai Intermediate Holdings, LLC
20.15. Azenta, Inc.
20.16. Bio-Synthesis, Inc.
20.17. Charles River Laboratories International, Inc.
20.18. CordenPharma International GmbH
20.19. Creative Biogene Inc.
20.20. Creative Biolabs, Inc.
20.21. Croda International Plc
20.22. Croyez Bioscience Co., Ltd.
20.23. Dr. Reddy's Laboratories Ltd.
20.24. Evonik Industries AG
20.25. Jena Bioscience GmbH
20.26. PackGene Biotech, Inc.
20.27. System Biosciences, LLC
20.28. Telesis Bio Inc.
21. Key Experts
LIST OF FIGURES
FIGURE 1. Global mRNA Synthesis & Manufacturing Market, Years Considered for the Study
FIGURE 2. Global mRNA Synthesis & Manufacturing Market, Research Design
FIGURE 3. Global mRNA Synthesis & Manufacturing Market, Research Framework
FIGURE 4. Global mRNA Synthesis & Manufacturing Market, Data Triangulation
FIGURE 5. Global mRNA Synthesis & Manufacturing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global mRNA Synthesis & Manufacturing Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global mRNA Synthesis & Manufacturing Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2025 vs 2032 (%)
FIGURE 9. Global mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global mRNA Synthesis & Manufacturing Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 11. Global mRNA Synthesis & Manufacturing Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global mRNA Synthesis & Manufacturing Market Size, by Manufacturing Process, 2025 vs 2032 (%)
FIGURE 13. Global mRNA Synthesis & Manufacturing Market Size, by Manufacturing Process, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global mRNA Synthesis & Manufacturing Market Size, by Manufacturing Scale, 2025 vs 2032 (%)
FIGURE 15. Global mRNA Synthesis & Manufacturing Market Size, by Manufacturing Scale, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global mRNA Synthesis & Manufacturing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 17. Global mRNA Synthesis & Manufacturing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global mRNA Synthesis & Manufacturing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 19. Global mRNA Synthesis & Manufacturing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global mRNA Synthesis & Manufacturing Market Size, by Usage, 2025 vs 2032 (%)
FIGURE 21. Global mRNA Synthesis & Manufacturing Market Size, by Usage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global mRNA Synthesis & Manufacturing Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 23. Global mRNA Synthesis & Manufacturing Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global mRNA Synthesis & Manufacturing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 25. Global mRNA Synthesis & Manufacturing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global mRNA Synthesis & Manufacturing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global mRNA Synthesis & Manufacturing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 28. Global mRNA Synthesis & Manufacturing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global mRNA Synthesis & Manufacturing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global mRNA Synthesis & Manufacturing Market Segmentation & Coverage
TABLE 2. Global mRNA Synthesis & Manufacturing Market Size, 2017-2032 (USD Million)
TABLE 3. Global mRNA Synthesis & Manufacturing Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Custom mRNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Custom mRNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Custom mRNA Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Client-Specific mRNA Orders Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Client-Specific mRNA Orders Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Client-Specific mRNA Orders Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Tailored Research Specifications Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Tailored Research Specifications Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Tailored Research Specifications Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Standard mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Standard mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Standard mRNA Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cataloged mRNA Variants Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Cataloged mRNA Variants Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Cataloged mRNA Variants Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Off-the-Shelf mRNA Selections Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Off-the-Shelf mRNA Selections Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Off-the-Shelf mRNA Selections Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2017-2032 (USD Million)
TABLE 23. Global Non-Replicating Linear mRNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Non-Replicating Linear mRNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Non-Replicating Linear mRNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Nucleoside-Modified Constructs Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Nucleoside-Modified Constructs Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Nucleoside-Modified Constructs Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Unmodified Nucleoside Constructs Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Unmodified Nucleoside Constructs Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Unmodified Nucleoside Constructs Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Self-Amplifying mRNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Self-Amplifying mRNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Self-Amplifying mRNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Alphavirus-Derived Replicons Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Alphavirus-Derived Replicons Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Alphavirus-Derived Replicons Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Flavivirus-Derived Replicons Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Flavivirus-Derived Replicons Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Flavivirus-Derived Replicons Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Circular RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Circular RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Circular RNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Enzymatic Ligation Circularization Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Enzymatic Ligation Circularization Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Enzymatic Ligation Circularization Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Chemical Ligation Circularization Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Chemical Ligation Circularization Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Chemical Ligation Circularization Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global mRNA Synthesis & Manufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 51. Global Materials & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Materials & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Materials & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global RNA Polymerases Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global RNA Polymerases Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global RNA Polymerases Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Capping Enzymes & Cap Analogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Capping Enzymes & Cap Analogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Capping Enzymes & Cap Analogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Nucleotides & Modified Nucleosides Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Nucleotides & Modified Nucleosides Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Nucleotides & Modified Nucleosides Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global DNA Templates & Plasmids Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global DNA Templates & Plasmids Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global DNA Templates & Plasmids Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Instruments & Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Instruments & Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Instruments & Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global IVT Reaction Systems & Mixers Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global IVT Reaction Systems & Mixers Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global IVT Reaction Systems & Mixers Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Chromatography Skids & Columns Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Chromatography Skids & Columns Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Chromatography Skids & Columns Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Tangential Flow Filtration Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Tangential Flow Filtration Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Tangential Flow Filtration Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Microfluidic Formulation Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Microfluidic Formulation Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Microfluidic Formulation Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Fill-Finish & Aseptic Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Fill-Finish & Aseptic Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Fill-Finish & Aseptic Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Software & Digital Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Software & Digital Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Software & Digital Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Electronic Batch Records Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Electronic Batch Records Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Electronic Batch Records Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Process Modeling & Digital Twins Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Process Modeling & Digital Twins Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Process Modeling & Digital Twins Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Data Integrity & Quality Management Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Data Integrity & Quality Management Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Data Integrity & Quality Management Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global LIMS & Laboratory Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global LIMS & Laboratory Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global LIMS & Laboratory Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Manufacturing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Manufacturing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Manufacturing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Sequence Design & Construct Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Sequence Design & Construct Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Sequence Design & Construct Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Process Development & Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Process Development & Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Process Development & Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global GMP Drug Product Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global GMP Drug Product Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global GMP Drug Product Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Technology Transfer & Scale-Up Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Technology Transfer & Scale-Up Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Technology Transfer & Scale-Up Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Testing & Release Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Testing & Release Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Testing & Release Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Method Development & Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Method Development & Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Method Development & Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global In-Process Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global In-Process Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global In-Process Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Release Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Release Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Release Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Stability Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Stability Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Stability Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Comparability & Characterization Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Comparability & Characterization Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Comparability & Characterization Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global mRNA Synthesis & Manufacturing Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 133. Global Advanced LNP Formulation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Advanced LNP Formulation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Advanced LNP Formulation Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Enzymatic Capping & Cap Analogues Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Enzymatic Capping & Cap Analogues Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Enzymatic Capping & Cap Analogues Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Genetic Engineering & Codon Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Genetic Engineering & Codon Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Genetic Engineering & Codon Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global In Vitro Transcription Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global In Vitro Transcription Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global In Vitro Transcription Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Plasmid DNA Template Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Plasmid DNA Template Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Plasmid DNA Template Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Polyadenylation Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Polyadenylation Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Polyadenylation Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global RNA Purification Techniques Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global RNA Purification Techniques Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global RNA Purification Techniques Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global mRNA Synthesis & Manufacturing Market Size, by Manufacturing Scale, 2017-2032 (USD Million)
TABLE 155. Global Commercial Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Commercial Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Commercial Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Lab Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Lab Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Lab Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Pilot Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Pilot Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Pilot Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global mRNA Synthesis & Manufacturing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Global In Vitro Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global In Vitro Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global In Vitro Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global In Vivo Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global In Vivo Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global In Vivo Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global mRNA Synthesis & Manufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Cancer immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Cancer immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Cancer immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Rare Genetic Disease Treatments Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Rare Genetic Disease Treatments Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Rare Genetic Disease Treatments Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Gene Editing Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Gene Editing Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Gene Editing Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Infectious Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Infectious Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Infectious Disease Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Veterinary Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Veterinary Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Veterinary Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Pandemic Preparedness Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Pandemic Preparedness Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Pandemic Preparedness Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Research & Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Research & Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Research & Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Preclinical Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Preclinical Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Preclinical Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Drug Discovery Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Drug Discovery Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Drug Discovery Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global mRNA Synthesis & Manufacturing Market Size, by Usage, 2017-2032 (USD Million)
TABLE 206. Global Human Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Global Human Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. Global Human Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 209. Global Veterinary Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global Veterinary Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global Veterinary Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global mRNA Synthesis & Manufacturing Market Size, by End-User, 2017-2032 (USD Million)
TABLE 213. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 215. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 216. Global Government Research Bodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Global Government Research Bodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. Global Government Research Bodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 219. Global University Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Global University Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. Global University Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 222. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 223. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 225. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 226. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 228. Global mRNA Synthesis & Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 229. Europe mRNA Synthesis & Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 230. Europe mRNA Synthesis & Manufacturing Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 231. Europe mRNA Synthesis & Manufacturing Market Size, by Custom mRNA Synthesis, 2017-2032 (USD Million)
TABLE 232. Europe mRNA Synthesis & Manufacturing Market Size, by Standard mRNA Production, 2017-2032 (USD Million)
TABLE 233. Europe mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2017-2032 (USD Million)
TABLE 234. Europe mRNA Synthesis & Manufacturing Market Size, by Non-Replicating Linear mRNA, 2017-2032 (USD Million)
TABLE 235. Europe mRNA Synthesis & Manufacturing Market Size, by Self-Amplifying mRNA, 2017-2032 (USD Million)
TABLE 236. Europe mRNA Synthesis & Manufacturing Market Size, by Circular RNA, 2017-2032 (USD Million)
TABLE 237. Europe mRNA Synthesis & Manufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 238. Europe mRNA Synthesis & Manufacturing Market Size, by Materials & Reagents, 2017-2032 (USD Million)
TABLE 239. Europe mRNA Synthesis & Manufacturing Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 240. Europe mRNA Synthesis & Manufacturing Market Size, by Software & Digital Solutions, 2017-2032 (USD Million)
TABLE 241. Europe mRNA Synthesis & Manufacturing Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 242. Europe mRNA Synthesis & Manufacturing Market Size, by Testing & Release Services, 2017-2032 (USD Million)
TABLE 243. Europe mRNA Synthesis & Manufacturing Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 244. Europe mRNA Synthesis & Manufacturing Market Size, by Manufacturing Scale, 2017-2032 (USD Million)
TABLE 245. Europe mRNA Synthesis & Manufacturing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. Europe mRNA Synthesis & Manufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. Europe mRNA Synthesis & Manufacturing Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 248. Europe mRNA Synthesis & Manufacturing Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 249. Europe mRNA Synthesis & Manufacturing Market Size, by Research & Discovery, 2017-2032 (USD Million)
TABLE 250. Europe mRNA Synthesis & Manufacturing Market Size, by Usage, 2017-2032 (USD Million)
TABLE 251. Europe mRNA Synthesis & Manufacturing Market Size, by End-User, 2017-2032 (USD Million)
TABLE 252. Europe mRNA Synthesis & Manufacturing Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 253. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 254. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 255. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Custom mRNA Synthesis, 2017-2032 (USD Million)
TABLE 256. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Standard mRNA Production, 2017-2032 (USD Million)
TABLE 257. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2017-2032 (USD Million)
TABLE 258. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Non-Replicating Linear mRNA, 2017-2032 (USD Million)
TABLE 259. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Self-Amplifying mRNA, 2017-2032 (USD Million)
TABLE 260. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Circular RNA, 2017-2032 (USD Million)
TABLE 261. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 262. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Materials & Reagents, 2017-2032 (USD Million)
TABLE 263. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 264. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Software & Digital Solutions, 2017-2032 (USD Million)
TABLE 265. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 266. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Testing & Release Services, 2017-2032 (USD Million)
TABLE 267. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 268. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Manufacturing Scale, 2017-2032 (USD Million)
TABLE 269. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 270. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 272. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 273. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Research & Discovery, 2017-2032 (USD Million)
TABLE 274. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Usage, 2017-2032 (USD Million)
TABLE 275. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by End-User, 2017-2032 (USD Million)
TABLE 276. Asia-Pacific mRNA Synthesis & Manufacturing Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 277. North America mRNA Synthesis & Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 278. North America mRNA Synthesis & Manufacturing Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 279. North America mRNA Synthesis & Manufacturing Market Size, by Custom mRNA Synthesis, 2017-2032 (USD Million)
TABLE 280. North America mRNA Synthesis & Manufacturing Market Size, by Standard mRNA Production, 2017-2032 (USD Million)
TABLE 281. North America mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2017-2032 (USD Million)
TABLE 282. North America mRNA Synthesis & Manufacturing Market Size, by Non-Replicating Linear mRNA, 2017-2032 (USD Million)
TABLE 283. North America mRNA Synthesis & Manufacturing Market Size, by Self-Amplifying mRNA, 2017-2032 (USD Million)
TABLE 284. North America mRNA Synthesis & Manufacturing Market Size, by Circular RNA, 2017-2032 (USD Million)
TABLE 285. North America mRNA Synthesis & Manufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 286. North America mRNA Synthesis & Manufacturing Market Size, by Materials & Reagents, 2017-2032 (USD Million)
TABLE 287. North America mRNA Synthesis & Manufacturing Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 288. North America mRNA Synthesis & Manufacturing Market Size, by Software & Digital Solutions, 2017-2032 (USD Million)
TABLE 289. North America mRNA Synthesis & Manufacturing Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 290. North America mRNA Synthesis & Manufacturing Market Size, by Testing & Release Services, 2017-2032 (USD Million)
TABLE 291. North America mRNA Synthesis & Manufacturing Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 292. North America mRNA Synthesis & Manufacturing Market Size, by Manufacturing Scale, 2017-2032 (USD Million)
TABLE 293. North America mRNA Synthesis & Manufacturing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. North America mRNA Synthesis & Manufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. North America mRNA Synthesis & Manufacturing Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 296. North America mRNA Synthesis & Manufacturing Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 297. North America mRNA Synthesis & Manufacturing Market Size, by Research & Discovery, 2017-2032 (USD Million)
TABLE 298. North America mRNA Synthesis & Manufacturing Market Size, by Usage, 2017-2032 (USD Million)
TABLE 299. North America mRNA Synthesis & Manufacturing Market Size, by End-User, 2017-2032 (USD Million)
TABLE 300. North America mRNA Synthesis & Manufacturing Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 301. Latin America mRNA Synthesis & Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 302. Latin America mRNA Synthesis & Manufacturing Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 303. Latin America mRNA Synthesis & Manufacturing Market Size, by Custom mRNA Synthesis, 2017-2032 (USD Million)
TABLE 304. Latin America mRNA Synthesis & Manufacturing Market Size, by Standard mRNA Production, 2017-2032 (USD Million)
TABLE 305. Latin America mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2017-2032 (USD Million)
TABLE 306. Latin America mRNA Synthesis & Manufacturing Market Size, by Non-Replicating Linear mRNA, 2017-2032 (USD Million)
TABLE 307. Latin America mRNA Synthesis & Manufacturing Market Size, by Self-Amplifying mRNA, 2017-2032 (USD Million)
TABLE 308. Latin America mRNA Synthesis & Manufacturing Market Size, by Circular RNA, 2017-2032 (USD Million)
TABLE 309. Latin America mRNA Synthesis & Manufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 310. Latin America mRNA Synthesis & Manufacturing Market Size, by Materials & Reagents, 2017-2032 (USD Million)
TABLE 311. Latin America mRNA Synthesis & Manufacturing Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 312. Latin America mRNA Synthesis & Manufacturing Market Size, by Software & Digital Solutions, 2017-2032 (USD Million)
TABLE 313. Latin America mRNA Synthesis & Manufacturing Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 314. Latin America mRNA Synthesis & Manufacturing Market Size, by Testing & Release Services, 2017-2032 (USD Million)
TABLE 315. Latin America mRNA Synthesis & Manufacturing Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 316. Latin America mRNA Synthesis & Manufacturing Market Size, by Manufacturing Scale, 2017-2032 (USD Million)
TABLE 317. Latin America mRNA Synthesis & Manufacturing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 318. Latin America mRNA Synthesis & Manufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. Latin America mRNA Synthesis & Manufacturing Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 320. Latin America mRNA Synthesis & Manufacturing Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 321. Latin America mRNA Synthesis & Manufacturing Market Size, by Research & Discovery, 2017-2032 (USD Million)
TABLE 322. Latin America mRNA Synthesis & Manufacturing Market Size, by Usage, 2017-2032 (USD Million)
TABLE 323. Latin America mRNA Synthesis & Manufacturing Market Size, by End-User, 2017-2032 (USD Million)
TABLE 324. Latin America mRNA Synthesis & Manufacturing Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 325. Africa mRNA Synthesis & Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 326. Africa mRNA Synthesis & Manufacturing Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 327. Africa mRNA Synthesis & Manufacturing Market Size, by Custom mRNA Synthesis, 2017-2032 (USD Million)
TABLE 328. Africa mRNA Synthesis & Manufacturing Market Size, by Standard mRNA Production, 2017-2032 (USD Million)
TABLE 329. Africa mRNA Synthesis & Manufacturing Market Size, by mRNA Modality, 2017-2032 (USD Million)
TABLE 330. Africa mRNA Synthesis & Manufacturing Market Size, by Non-Replicating Linear mRNA, 2017-2032 (USD Million)
TABLE 331. Africa mRNA Synthesis & Manufacturing Market Size, by Self-Amplifying mRNA, 2017-2032 (USD Million)
TABLE 332. Africa mRNA Synthesis & Manufacturing Market Size, by Circular RNA, 2017-2032 (USD Million)
TABLE 333. Africa mRNA Sy

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Lonza Group Ltd.
  • Samsung Biologics Co., Ltd.
  • Sartorius AG
  • WuXi Biologics (Cayman) Inc.
  • Catalent, Inc.
  • ST Pharm Co., Ltd.
  • GenScript Biotech Corporation
  • Promega Corporation
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • TriLink BioTechnologies LLC by Maravai Intermediate Holdings, LLC
  • Azenta, Inc.
  • Bio-Synthesis, Inc.
  • Charles River Laboratories International, Inc.
  • CordenPharma International GmbH
  • Creative Biogene Inc.
  • Creative Biolabs, Inc.
  • Croda International Plc
  • Croyez Bioscience Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Evonik Industries AG
  • Jena Bioscience GmbH
  • PackGene Biotech, Inc.
  • System Biosciences, LLC
  • Telesis Bio Inc.

Related Topics

Related Reports

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report by Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), Application (Vaccine Production, Therapeutics Production), End Use, and Region with Growth Forecasts, 2026-2033 - Product Image

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report by Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), Application (Vaccine Production, Therapeutics Production), End Use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Messenger Ribonucleic Acid (mRNA) Synthesis and Manufacturing Market Report 2026 - Product Image

Messenger Ribonucleic Acid (mRNA) Synthesis and Manufacturing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
mRNA Synthesis Raw Materials - Global Strategic Business Report - Product Image

mRNA Synthesis Raw Materials - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2026 - Product Image

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2026

  • Report
  • 250 Pages
  • Global
From
MRNA Synthesis Service - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

MRNA Synthesis Service - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.